HS1BP3 inhibitors are a class of chemical compounds that specifically target HS1-binding protein 3 (HS1BP3), a regulator involved in cellular processes like actin cytoskeleton organization and vesicle trafficking. HS1BP3 interacts with a variety of proteins associated with the cytoskeleton, particularly those involved in the dynamic rearrangement of actin filaments, which are crucial for cell movement, division, and intracellular transport. By inhibiting HS1BP3, these compounds can disrupt these fundamental processes, leading to alterations in cellular organization and the movement of vesicles within the cell. The inhibition of HS1BP3 is used in research to explore how the regulation of the cytoskeleton and related pathways influences cell behavior and organization.
In research, HS1BP3 inhibitors help to elucidate the role of HS1BP3 in various cellular mechanisms, including its involvement in endocytosis and membrane trafficking. By studying the effects of these inhibitors, researchers gain a better understanding of how HS1BP3 contributes to the coordination of vesicle formation, fusion, and transport, particularly in relation to the Golgi apparatus and the plasma membrane. Additionally, these inhibitors can be employed to examine the connections between HS1BP3 and other signaling pathways that regulate cell morphology and communication. The use of HS1BP3 inhibitors in experimental settings provides valuable insights into the regulation of actin dynamics, intracellular transport, and the broader network of protein-protein interactions essential for maintaining cellular architecture and function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibits PI3K, which can impact the PI3K/AKT signaling pathway, potentially affecting HS1BP3's role in this pathway. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Inhibits PI3K, can disrupt PI3K/AKT signaling, potentially altering HS1BP3 activity if it's involved in this pathway. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Inhibits MEK1/2, which can affect the MAPK/ERK pathway, potentially influencing HS1BP3's function if it's part of this signaling cascade. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAPK, which can affect stress response pathways, potentially influencing HS1BP3's function within these pathways. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, which can modulate stress response and apoptosis pathways, potentially altering HS1BP3's activity if it's involved in these processes. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR, which can affect protein synthesis and autophagy, potentially influencing HS1BP3's role in these processes. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
Inhibits Src family kinases, which can disrupt signaling pathways, potentially altering HS1BP3's activity if it's associated with these kinases. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Inhibits ROCK, which can impact actin cytoskeleton organization, potentially affecting HS1BP3's function if it's involved in cytoskeletal regulation. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), which can disrupt calcium homeostasis, potentially impacting HS1BP3's function if it's involved in calcium signaling. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
Chelates intracellular calcium, which can disrupt calcium signaling, potentially affecting HS1BP3's function if it's involved in these pathways. | ||||||